Genomas gets $1.2M donacja for genomic side-effect.

Genomas gets $1.2M donacja for genomic side-effect tests – Genomas, a Hartford, Conn., personalized-medicine startup, received a $1.2 million small business-innovation donacja from the NIH. The grant will fund genetic work aimed at identifying people who are most likely to suffer painful side effects from cholesterol-lowering statin drugs..

Original text search at: venturebeat.com/index.php?tag=antibiotics

Comments are closed.